4//SEC Filing
CARPENTER CHRISTOPHER L. 4
Accession 0001104659-19-037241
CIK 0001709401other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:02 PM ET
Size
9.0 KB
Accession
0001104659-19-037241
Insider Transaction Report
Form 4
CARPENTER CHRISTOPHER L.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-06-20$2.87/sh+243$697→ 35,086 total - Sale
Common Stock
2019-06-20$13.93/sh−243$3,386→ 34,843 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-06-20−243→ 619,157 totalExercise: $2.87Exp: 2027-10-24→ Common Stock (243 underlying)
Footnotes (3)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.79 to $14.03, inclusive. The reporting person undertakes to provide to Rubius Therapeutics, Inc., any security holder of Rubius Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]25% of this option shall vest on September 18, 2018, then in 12 equal quarterly installments thereafter.
Documents
Issuer
Rubius Therapeutics, Inc.
CIK 0001709401
Entity typeother
Related Parties
1- filerCIK 0001746845
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:02 PM ET
- Size
- 9.0 KB